TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,538 JPY | -1.40% |
|
-3.06% | +9.84% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
| Sales 2024 * | 905B 5.86B | Sales 2025 * | 971B 6.29B | Capitalization | 3,823B 24.74B |
|---|---|---|---|---|---|
| Net income 2024 * | 108B 701M | Net income 2025 * | 125B 810M | EV / Sales 2024 * | 4.25 x |
| Net Debt 2024 * | 23.33B 151M | Net cash position 2025 * | 55.65B 360M | EV / Sales 2025 * | 3.88 x |
| P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
30.6
x | Employees | 30,207 |
| Yield 2024 * |
0.84% | Yield 2025 * |
0.93% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | -1.40% | ||
| 1 week | -3.06% | ||
| Current month | -6.98% | ||
| 1 month | -10.24% | ||
| 3 months | +0.44% | ||
| 6 months | +31.80% | ||
| Current year | +9.84% |
1 week
2 513.00
2 661.50
1 month
2 513.002 890.00
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
488.503 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 81-03-31 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 83-03-31 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 20-06-24 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 04-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 31 M€ | +7.88% | ||
| 1.94% | 31,732 M€ | +11.76% | - | |
| 1.93% | 1,198 M€ | +11.02% | - | |
| 1.90% | 16,729 M€ | +10.93% | - | |
| 1.82% | 67,864 M€ | +11.66% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 2,538 | -1.40% | 3 972 900 |
| 24-04-18 | 2,574 | -0.85% | 3,006,400 |
| 24-04-17 | 2,596 | -1.68% | 2,613,400 |
| 24-04-16 | 2,641 | +2.07% | 3,536,500 |
| 24-04-15 | 2,588 | -1.18% | 2,329,700 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-14
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,574
JPY
Average target price
2,951
JPY
Spread / Average Target
+14.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.84% | 24.73B | |
| -4.36% | 183B | |
| -3.87% | 105B | |
| -4.38% | 67.36B | |
| +8.23% | 51.77B | |
| +15.54% | 47.29B | |
| -1.73% | 40.2B | |
| +7.16% | 27.62B | |
| -16.51% | 21.75B | |
| -1.68% | 25.51B |
- Stock Market
- Equities
- 4543 Stock
